1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Longwood Capital Partners LLC Buys Insmed Inc, Dermira Inc, CymaBay Therapeutics Inc, Sells Amarin Corp PLC, Chembio Diagnostics Inc

Portola Valley, CA, based Investment company Longwood Capital Partners LLC buys Insmed Inc, Dermira Inc, CymaBay Therapeutics Inc, Enanta Pharmaceuticals Inc, Dicerna Pharmaceuticals Inc, Adverum Biotechnologies Inc, Arvinas Inc, Protagonist Therapeutics Inc, ViewRay Inc, Arrowhead Pharmaceuticals Inc, Mirati Therapeutics Inc, Quotient, Immunomedics Inc, Allakos Inc, sells Amarin Corp PLC, Chembio Diagnostics Inc during the 3-months ended 2019Q1, according to the most recent filings of the investment company, Longwood Capital Partners LLC. As of 2019Q1, Longwood Capital Partners LLC owns 30 stocks with a total value of $205 million. These are the details of the buys and sells.

For the details of Longwood Capital Partners LLC's stock buys and sells, go to https://www.gurufocus.com/guru/longwood+capital+partners+llc/current-portfolio/portfolio

These are the top 5 holdings of Longwood Capital Partners LLC
  1. Iovance Biotherapeutics Inc (IOVA) - 2,944,201 shares, 13.67% of the total portfolio. Shares reduced by 2.48%
  2. Kadmon Holdings Inc (KDMN) - 7,635,000 shares, 9.84% of the total portfolio. Shares added by 1.29%
  3. Assembly Biosciences Inc (ASMB) - 760,500 shares, 7.31% of the total portfolio. Shares added by 5.85%
  4. CAS Medical Systems Inc (CASM) - 5,263,508 shares, 6.25% of the total portfolio.
  5. Insmed Inc (INSM) - 370,000 shares, 5.25% of the total portfolio. New Position
New Purchase: Insmed Inc (INSM)

Longwood Capital Partners LLC initiated holding in Insmed Inc. The purchase prices were between $13.12 and $31.15, with an estimated average price of $25.71. The stock is now traded at around $27.68. The impact to a portfolio due to this purchase was 5.25%. The holding were 370,000 shares as of .

New Purchase: Dermira Inc (DERM)

Longwood Capital Partners LLC initiated holding in Dermira Inc. The purchase prices were between $6.19 and $14.13, with an estimated average price of $8.29. The stock is now traded at around $10.15. The impact to a portfolio due to this purchase was 4.21%. The holding were 636,500 shares as of .

New Purchase: CymaBay Therapeutics Inc (CBAY)

Longwood Capital Partners LLC initiated holding in CymaBay Therapeutics Inc. The purchase prices were between $7.87 and $13.42, with an estimated average price of $10.56. The stock is now traded at around $12.36. The impact to a portfolio due to this purchase was 3.36%. The holding were 517,500 shares as of .

New Purchase: Enanta Pharmaceuticals Inc (ENTA)

Longwood Capital Partners LLC initiated holding in Enanta Pharmaceuticals Inc. The purchase prices were between $69.08 and $105.66, with an estimated average price of $89.42. The stock is now traded at around $84.16. The impact to a portfolio due to this purchase was 2.85%. The holding were 61,000 shares as of .

New Purchase: Dicerna Pharmaceuticals Inc (DRNA)

Longwood Capital Partners LLC initiated holding in Dicerna Pharmaceuticals Inc. The purchase prices were between $9.74 and $14.65, with an estimated average price of $11.47. The stock is now traded at around $10.78. The impact to a portfolio due to this purchase was 2.35%. The holding were 328,825 shares as of .

New Purchase: Adverum Biotechnologies Inc (ADVM)

Longwood Capital Partners LLC initiated holding in Adverum Biotechnologies Inc. The purchase prices were between $3.03 and $6.02, with an estimated average price of $4.01. The stock is now traded at around $6.33. The impact to a portfolio due to this purchase was 2.35%. The holding were 919,000 shares as of .

Added: ViewRay Inc (VRAY)

Longwood Capital Partners LLC added to a holding in ViewRay Inc by 161.64%. The purchase prices were between $5.7 and $8.73, with an estimated average price of $7.69. The stock is now traded at around $8.19. The impact to a portfolio due to this purchase was 1.82%. The holding were 815,000 shares as of .

Added: Immunomedics Inc (IMMU)

Longwood Capital Partners LLC added to a holding in Immunomedics Inc by 25.00%. The purchase prices were between $13.12 and $19.21, with an estimated average price of $16.02. The stock is now traded at around $14.90. The impact to a portfolio due to this purchase was 0.94%. The holding were 500,000 shares as of .



Here is the complete portfolio of Longwood Capital Partners LLC. Also check out:

1. Longwood Capital Partners LLC's Undervalued Stocks
2. Longwood Capital Partners LLC's Top Growth Companies, and
3. Longwood Capital Partners LLC's High Yield stocks
4. Stocks that Longwood Capital Partners LLC keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK